Patents by Inventor Anthony FARGNOLI

Anthony FARGNOLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anc80 encoding sphingolipid-metabolizing proteins for mitigating disease-induced tissue damage
    Patent number: 11618893
    Abstract: The present disclosure relates generally to the use of sphingolipid-metabolizing proteins to mitigate or minimize tissue damage resulting from injury or from disease, for example, pulmonary arterial hypertension (PAH) when the sphingolipid-metabolizing protein is delivered via expression from an Anc80 vector.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: April 4, 2023
    Assignee: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    Inventors: Efrat Eliyahu, Adam Vincek, Anthony Fargnoli, Michael Katz
  • ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS FOR MITIGATING DISEASE-INDUCED TISSUE DAMAGE
    Publication number: 20220347276
    Abstract: The present disclosure relates generally to the use of sphingolipid-metabolizing proteins to mitigate or minimize tissue damage resulting from injury or from disease, for example, pulmonary arterial hypertension (PAH) when the sphingolipid-metabolizing protein is delivered via expression from an Anc80 vector.
    Type: Application
    Filed: September 11, 2019
    Publication date: November 3, 2022
    Inventors: Efrat ELIYAHU, Adam VINCEK, Anthony FARGNOLI, Michael KATZ